Monday, May 1, 2017

OFFICE CLOSURES FOR NOVEMBER/DECEMBER

PLEASE MARK YOUR CALENDARS




The office will be closed on the following days in November/December:  


  • Wednesday, Nov. 21st
  • Thursday, Nov. 22nd
  • Wednesday, Dec. 12th - Shot hours will be from 8:30-12:30 p.m. and 2:00-5:00 p.m.
  • We will be closed from Monday, Dec. 24th thru Tuesday, Jan. 1st, 2019.
  • Normal business hours will resume on Wednesday, Jan. 2nd.


Effective December 13th, office hours for Thursdays will be as follows:


  • 8:30 a.m. - 4:30 p.m.  Allergy shots will be available through the lunch hour on Thursdays only.


Please continue to check this site for any updates on our office schedule.


Monday, April 3, 2017

There is a recall on certain epipens.
In the United States, the recall applies to 13 lots of both EpiPen and EpiPen Jr. auto-injectors distributed between December 17, 2015, and July 1, 2016. Patients can receive another EpiPen or an authorized generic version at their pharmacy, Mylan said. In the meantime, they should continue to carry and use their current EpiPen until they acquire a replacement.
Product/Dosage
NDC Number
Lot Number
Expiration Date
EpiPen Jr Auto-Injector, 0.15 mg
49502-501-02
5GN767
April 2017
EpiPen Jr Auto-Injector, 0.15 mg
49502-501-02
5GN773
April 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
5GM631
April 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
5GM640
May 2017
EpiPen Jr Auto-Injector, 0.15 mg
49502-501-02
6GN215
September 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
6GM082
September 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
6GM072
September 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
6GM081
September 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
6GM088
October 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
6GM199
October 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
6GM091
October 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
6GM198
October 2017
EpiPen Auto-Injector, 0.3 mg
49502-500-02
6GM087
October 2017
Source: FDA
For further assistance, EpiPen users can contact Mylan at 800-796-9526 or email customer service at customer.service@mylan.com.

Wednesday, March 22, 2017

Epinephrine auto-injectors are now available as a generic.
Please ask the nurse if you want your epi-pen prescription changed to generic as it may be more affordable.
Publix now has Montelukast (Singulair) for FREE
(4mg chewable, 5mg chewable, 10mg tablet)
(1-90 day supply)


Please ask the nurse if you want your prescription sent to Publix

Thursday, January 12, 2017

SECURE, EASY WAY TO PAY!!

SUNSHINE ALLERGY HAS NOW MADE PAYING YOUR BILL EVEN EASIER.

PAY YOUR BALANCE THROUGH OUR WEBSITE USING PAYPAL--A SECURE, USER-FRIENDLY CLICK OF A BUTTON!

IF YOU HAVE QUESTIONS, PLEASE FEEL FREE TO CALL US AT (727) 787-6744.

Wednesday, August 24, 2016

EFFECTIVE IMMEDIATELY, DAILY SHOT HOURS WILL END AT 12:30 P.M. FOR THE MORNING AND RESUME AT 2:00 P.M. FOR THE AFTERNOON.

Wednesday, December 2, 2015

VITAMIN B12 SHOTS NOW AVAILABLE - PLEASE CALL OUR OFFICE FOR DETAILS

 Why B12?


1.  Great source of healthy energy and reduces fatigue
2.  Helps support natural weight loss
3.  Improves sleep
4.  100% absorption compared to 1% when taken orally
5.  Supports the immune system to fight infections


Who Benefits?


1.  Individuals living stressful lives
2.  Seniors
3.  Athletes
4.  Those who drink alcohol
5.  Vegetarians/Vegans (Vitamin B12 is mostly found in animal products.)
6.  Pregnant or nursing women


How does B12 work?


Vitamin B12 is required for the proper function and development of the brain, nerves, blood cells and many other parts of the body.

Thursday, October 29, 2015

RECALL ON AUVI-Q EPINEPHRINE AUTO-INJECTORS


Please be advised that Sanofi has voluntarily recalled the Auvi-Q epinephrine auto-injectors citing the possibility of the device delivering a wrong-sized dose.  You may call (866)726-6340 to get information on how to return your Auvi-Q and get a refund or cost of a new injector. 

Follow this link for more information:  www.Auvi-Q.com

Monday, June 22, 2015

In June 2015, the FDA approved a new medication called Mepolizumab for the treatment of severe eosinophilic asthma in patients 18 years or older.  This is an exciting advancement in the treatment of asthma for those patients who are on high doses of inhaled steroids and continue to have regular exacerbations, frequent visits to emergency rooms or hospitalizations or are dependent on steroids such as prednisone.  This new medication has been shown to reduce rates of hospitalizations or ER visits and also reduce rates of asthma exacerbation. Dr. Kim feels that Mepolizumab will be a potent medication to help control severe asthma.  Ask the doctors at Sunshine Allergy about your  medications if your asthma is difficult to control.
http://www.reuters.com/article/2015/06/11/us-glaxosmithkline-asthma-fda-idUSKBN0OR2N720150611

Saturday, June 13, 2015

Welcome to Sunshine Allergy!

Please check back on our page for news, information, and educational material relating to Sunshine Allergy & Allergy Education.